RTSM Red Flags in Clinical Trials: When It's Time To Switch IRT/RTSM Software

Clinical teams often recognize when their RTSM isn’t working as it should — delayed updates, sluggish support, inflexible configurations, or persistent data issues. But identifying why these problems occur, and when they signal deeper system risk, isn’t always straightforward. In this clip, Chuck Harris outlines the most important warning signs teams should pay attention to before those frustrations begin to impact trial performance.

He discusses the operational patterns that typically precede larger issues, from timelines that repeatedly slip to systems that can’t adapt when study realities change. These signals aren’t just inconveniences; they can shape site experience, data quality, and a sponsor’s ability to execute against the protocol.

Harris also offers guidance on how to evaluate whether an RTSM is still serving the needs of an active study — or if it’s time to consider a different path. The conversation provides a practical framework for recognizing risk early and making informed decisions that protect trial continuity.